Browsing: AVXL

ANAVEX LIFE SCIENCES CORP. (AVXL) filed an amended annual report to revise its assessment of internal control over financial reporting as of September 30, 2025. After a Special Committee review and the April 30, 2026 termination of the former CEO’s employment for Cause, management and the Audit Committee concluded a material weakness existed at September…

ANAVEX LIFE SCIENCES CORP. (AVXL) filed an Amendment No. 1 to its Form 10‑Q for the quarter ended December 31, 2025. After a review overseen by a special committee and the Audit Committee, management reassessed disclosure controls and internal control over financial reporting as of that date.